Although long-acting GLP-1 receptor agonists commonly cause nausea, the side effect is typically short-lived, and patients generally tolerate the treatment well
The most commonly reported side effects were gastrointestinal, such as nausea, vomiting, diarrhoea, or constipation
Patients with T2DM tend to secrete less insulin following a glucose-heavy meal possibly due to decreased levels of glucagon-like peptide-1 (GLP-1) [96]
The Food and Drug Administration is cracking down on telehealth companies marketing of compounded versions of weight loss drugs
It is not available through NHS prescribing, nor is it formally listed by any private pharmacy or specialist clinic as an approved treatment option
For example, berberine, often called natures Ozempic, has been shown to improve insulin sensitivity, reduce blood sugar levels, and potentially promote mild weight loss by activating an enzyme called AMPK, which regulates metabolism and energy use